Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Recall alert: Do you use this dog food?

Here's everything you need to know to keep your best friend safe

Salon

ATE.TO: Phase 2 Post-Operative Pain Program to Initiate in Calendar 4Q22…

By David Bautz, PhD OTC:ATBPF | TSX:ATE.TO READ THE FULL ATE.TO RESEARCH REPORT

Benzinga

Biden signs executive order to protect US abortion access and urges Americans to ‘vote, vote, vote’ – as it happened

US president says electing senators who would help codify Roe v Wade is the ‘fastest route’ to solidifying federal abortion rights – follow the latest

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

The Food & Drug Administration Has a Vaping Problem

Something is wrong at the Food & Drug Administration's Center for Tobacco Products, and federal courts are beginning to notice.

Reason

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

StockNews.com

‘Wellness’ vapes are all the rage. But are they healthy or just hype?

These ‘nutritional supplement diffusers’ claim to fight ADHD or treat anxiety or depression, but experts remain wary of effects

The Guardian - US

Can a Target gift card help you stay off meth? This program is trying it

LOS ANGELES — Mark had been wanting to quit using meth for a while when someone pointed him to the folding table propped up at the skid row site where homeless people stop for showers and laundry.

Los Angeles Times

Read news from The Economist, FT, and more,
with one subscription

This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

Benzinga

Lisa Jarvis: Abortion pill won’t be the only one restricted by state bans

It’s not yet two weeks since the Supreme Court overturned Roe v. Wade, and already the ruling is impeding people’s access to drugs — including drugs not being used for abortions.

Tribune News Service

FDA Finally Admits It Caused the Baby Formula Shortage

The agency is now taking small steps to allow foreign formula manufacturers to import their goods into the U.S.

Reason

This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.

Benzinga

Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims

U.S. stocks traded higher this morning, following the release of data on initial jobless claims.

Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Elon Musk's Kids, Apple's Potential Security Measure, Covid-19 Vaccine Wastage And Other Top Financial Stories Thursday, July 7

CNBC

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

What’s in your sports supplement? New paper warns of accidental doping

Murky federal regulations and misleading labeling practices make determining the true ingredients of sports supplements near impossible.

Benzinga

Coinbase, Moderna And 56 Biggest Movers From Yesterday

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.

The Independent UK

Pig heart transplant recipient died of heart failure

‘But we don’t consider this a setback,’ says doctor who co-led groundbreaking surgery

The Independent UK

AP News Digest 3 a.m.

Here are the AP’s latest coverage plans, top stories and promotable content. All times EDT. For up-to-the minute information on AP’s coverage, visit Coverage Plan at https://newsroom.ap.org.

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

Omicron boosters could be here by fall

As viruses morph and adapt, there's a greater call for targeted vaccines and boosters

Benzinga

What's Going On With Altria Stock Today?

Altria Group Inc (NYSE: MO) shares are trading higher Wednesday after the U.S. Food and Drug Administration temporarily suspended the ban of Juul e-cigarette sales.

Benzinga

Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial

Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. SRP-9001 is an investigational gene therapy under development in partnership with Roche Holdings AG (OTC:RHHBY). Results from Cohort 1 demonstrated a 3.8-point improvement and 3.2-point improvement on the Duchenne functional scale 52 weeks after…

Benzinga

Coherus's Refiling For Head and Neck Cancer Candidate Accepted By FDA For Review

Coherus BioSciences (NASDAQ: CHRS) announced that the United States Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for Toripalimab in combination with Gemcitabine and Cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasophar

Benzinga

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

InflaRx's Stock Gains Following FDA Fast Track Status To Skin Disease Drug

The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG).

Benzinga

Benzinga Before The Bell: FDA Temporarily Suspends Juul Ban, FTX Wants Bitcoin Derivatives, Voyager Digital Files For Chapter 11 Bankruptcy And Other Top Financial Stories Wednesday, July 6

CNBC Ben & Jerry’s Sues Parent Unilever On Israeli business Sale

1 … 180 181 182 183

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.